Abstract
Background
Appendicular skeletal muscle mass index and muscle attenuation (density) are negatively associated with mortality in European-derived populations.
Objectives
The present analyses assessed association between axial skeletal muscle density and muscle index with mortality in European Americans with type 2 diabetes mellitus (T2D).
Design
Single-center observational study.
Setting
Diabetes Heart Study.
Participants
839 European Americans with T2D.
Methods
Computed tomography-measured psoas and paraspinous muscle mass index (cross sectional area/height2) and radiographic density (Hounsfield Units) were assessed in all participants. A Cox proportional hazards model was computed. The fully-adjusted model included covariates age, sex, body mass index, smoking, alcohol use, diabetes duration, insulin use, hormone replacement therapy (women), prevalent cardiovascular disease (CVD), hypertension, and coronary artery calcified atherosclerotic plaque mass score. Deaths were recorded in the National Death Index data through December 31, 2015.
Results
Participants included 428 women and 411 men with median (25th, 75th quartile) age 62.8 (56.1, 69.1) years and diabetes duration 8.0 (5.0, 14.0) years. After 11.9 (9.4, 13.3) years of follow-up, 314 (37.4%) of participants were deceased. In the fully-adjusted model, psoas muscle density (hazard ratio [HR] 0.81, plt;0.001), psoas muscle index (HR 0.82, p=0.008), and paraspinous muscle density (HR 0.85, p=0.003) were inversely associated with mortality. Paraspinous muscle index was not significantly associated with mortality (HR 0.90, p=0.08). Results did not differ significantly between men and women.
Conclusions
In addition to established risk factors for mortality and CVD, higher psoas muscle index, psoas muscle density, and paraspinous muscle density were significantly associated with lower all-cause mortality in European Americans with T2D.
Similar content being viewed by others
References
Sinclair AJ, Abdelhafiz AH, Rodriguez–Manas L. Frailty and sarcopenia–newly emerging and high impact complications of diabetes. J Diabetes Complications 2017;31(9):1465–73.
Vellas B, Fielding R, Bhasin S, et al. Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging 2016;5(4):194–200.
Murphy RA, Reinders I, Garcia ME, et al. Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care 2014;37(12):3213–9.
Lopez–Jaramillo P, Cohen DD, Gomez–Arbelaez D, et al. Association of handgrip strength to cardiovascular mortality in pre–diabetic and diabetic patients: a subanalysis of the ORIGIN trial. Int J Cardiol 2014;174(2):458–61.
Kim YK, Lee HS, Ryu JJ, In LH, Seo SG. Sarcopenia increases the risk for mortality in patients who undergo amputation for diabetic foot. J Foot Ankle Res 2018;11:32.
Murea M, Lenchik L, Register TC, et al. Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus. J Diabetes Complications 2018;32(6):558–564..
Lenchik L, Boutin RD. Sarcopenia: Beyond Muscle Atrophy and into the New Frontiers of Opportunistic Imaging, Precision Medicine, and Machine Learning. Semin Musculoskelet Radiol 2018;22(3):307–22.
Daly LE, Prado CM, Ryan AM. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes. Proc Nutr Soc 2018;77(2):135–51.
Peterson SJ, Braunschweig CA. Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting. Nutr Clin Pract 2016;31(1):40–8.
Kalyani RR, Corriere M, Ferrucci L. Age–related and disease–related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014;2(10):819–29.
Wagenknecht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BI, Rich SS. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001;50(4):861–6.
Bowden DW, Cox AJ, Freedman BI, et al. Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud 2010;7(3):188–201.
Larsen BA, Wassel CL, Kritchevsky SB, et al. Association of Muscle Mass, Area, and Strength With Incident Diabetes in Older Adults: The Health ABC Study. J Clin Endocrinol Metab 2016;101(4):1847–55.
Cuthbertson DJ, Bell JA, Ng SY, Kemp GJ, Kivimaki M, Hamer M. Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing. Diabet Med 2016;33(8):1052–9.
Lee CG, Boyko EJ, Strotmeyer ES, et al. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc 2011;59(7):1217–24.
Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: A cross talk between age–associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 2017;35:200–21.
Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well–functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2003;51(3):323–30.
Gallagher D, Kuznia P, Heshka S, et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 2005;81(4):903–10.
Albu JB, Kovera AJ, Allen L, et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 2005;82(6):1210–7.
Miljkovic I, Cauley JA, Petit MA, et al. Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry. J Clin Endocrinol Metab 2009;94(8):2735–42.
Miljkovic I, Kuipers AL, Cvejkus R, et al. Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obesity (Silver Spring) 2016;24(2):476–82.
Zhao Q, Zmuda JM, Kuipers AL, et al. Greater skeletal muscle fat infiltration is associated with higher all–cause mortality among men of African ancestry. Age Ageing 2016;45(4):529–34.
Boutin RD, Bamrungchart S, Bateni CP, et al. CT of Patients With Hip Fracture: Muscle Size and Attenuation Help Predict Mortality. AJR Am J Roentgenol 2017;208(6):W208–W215.
Stuart CA, McCurry MP, Marino A, et al. Slow–twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 2013;98(5):2027–36.
Arbanas J, Klasan GS, Nikolic M, Jerkovic R, Miljanovic I, Malnar D. Fibre type composition of the human psoas major muscle with regard to the level of its origin. J Anat 2009;215(6):636–41.
Leeper CM, Lin E, Hoffman M, et al. Computed tomography abbreviated assessment of sarcopenia following trauma: The CAAST measurement predicts 6–month mortality in older adult trauma patients. J Trauma Acute Care Surg 2016;80(5):805–11.
Therkelsen KE, Pedley A, Speliotes EK, et al. Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2013;33(4):863–70.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Tucker, B.M., Hsu, F.C., Register, T.C. et al. Psoas and Paraspinous Muscle Measurements on Computed Tomography Predict Mortality in European Americans with Type 2 Diabetes Mellitus. J Frailty Aging 8, 72–78 (2019). https://doi.org/10.14283/jfa.2019.5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14283/jfa.2019.5